Literature DB >> 30420256

Cytoreductive Nephrectomy: Assessing the Generalizability of the CARMENA Trial to Real-world National Cancer Data Base Cases.

Sohrab Arora1, Akshay Sood1, Deepansh Dalela1, Hoang J Tang1, Amit Patel1, Jacob Keeley1, Quoc-Dien Trinh2, Craig G Rogers1, Mani Menon1, Firas Abdollah3.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30420256     DOI： 10.1016/j.eururo.2018.10.054

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  9 in total

Review 1.  Redefining the Role of Surgical Management of Metastatic Renal Cell Carcinoma.

Authors:  Walter R Hsiang; Patrick A Kenney; Michael S Leapman
Journal:  Curr Oncol Rep       Date:  2020-03-13       Impact factor: 5.075

2.  Current role of cytoreductive nephrectomy in metastatic renal cell carcinoma.

Authors:  Charles Van Praet; Charlotte Slots; Nikhil Vasdev; Sylvie Rottey; Valérie Fonteyne; Iulia Andras; Maarten Albersen; Gert De Meerleer; Axel Bex; Karel Decaestecker
Journal:  Turk J Urol       Date:  2021-02

Review 3.  Immune checkpoint blockade in renal cell carcinoma.

Authors:  Phillip M Rappold; Andrew W Silagy; Ritesh R Kotecha; Ari A Hakimi
Journal:  J Surg Oncol       Date:  2021-03       Impact factor: 3.454

4.  A qualitative framework of non-selection factors for cytoreductive nephrectomy.

Authors:  Andrew W Silagy; Kyrollis Attalla; Renzo G Dinatale; Kate L Weiss; Stanley Weng; Roy Mano; Skylar Iosepovici; Julian Marcon; Ed Reznik; Ritesh R Kotecha; Robert J Motzer; Martin H Voss; Jonathan A Coleman; A Ari Hakimi; Paul Russo
Journal:  World J Urol       Date:  2021-03-29       Impact factor: 3.661

Review 5.  Clinical Trial Generalizability Assessment in the Big Data Era: A Review.

Authors:  Zhe He; Xiang Tang; Xi Yang; Yi Guo; Thomas J George; Neil Charness; Kelsa Bartley Quan Hem; William Hogan; Jiang Bian
Journal:  Clin Transl Sci       Date:  2020-04-10       Impact factor: 4.689

6.  The Effect of Cytoreductive Partial Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma.

Authors:  Jiabi Chen; Qingliu He; Weihui Liu; Yining Li; Wei Zhuang
Journal:  Clin Interv Aging       Date:  2020-03-20       Impact factor: 4.458

7.  Cytoreductive nephrectomy for metastatic renal cell carcinoma, the ultimate urologic 'Choosing Wisely' campaign: a narrative review.

Authors:  Alexandra L Tabakin; Mark N Stein; Christopher B Anderson; Charles G Drake; Eric A Singer
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

8.  Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study.

Authors:  Renpei Kato; Sei Naito; Kazuyuki Numakura; Shingo Hatakeyama; Tomoyuki Koguchi; Takahiro Kojima; Yoshihide Kawasaki; Shuya Kandori; Sadafumi Kawamura; Yoichi Arai; Akihiro Ito; Hiroyuki Nishiyama; Yoshiyuki Kojima; Chikara Ohyama; Tomonori Habuchi; Norihiko Tsuchiya; Wataru Obara
Journal:  Int J Clin Oncol       Date:  2022-01-01       Impact factor: 3.402

9.  Clinical comparison between trial participants and potentially eligible patients using electronic health record data: A generalizability assessment method.

Authors:  James R Rogers; George Hripcsak; Ying Kuen Cheung; Chunhua Weng
Journal:  J Biomed Inform       Date:  2021-05-25       Impact factor: 8.000
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.